What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Pharmaceutical Excipients Market by Type (Organic Chemicals, inorganic Chemicals, Others), Functionality, Formulation, Regions, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

Publish Date: May, 2019
Report ID: 386021
Category: Pharmaceuticals and Healthcare
Pages: 0

$4700

Global pharmaceutical excipients market is expected to reach USD 9.78 Billion by 2025, at a CAGR of 5.93% from 2018 to 2025. Rapid growth of the pharmaceutical industry, increasing geriatric population, rising prevalence of chronic diseases, advancements in functional excipients and the swiftly growing biopharmaceuticals sector are driving the growth of the global pharmaceutical excipients market.

Market Overview:

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. Pharmaceutical excipients are used in the pharmaceutical drugs for the purposes of aiding the manufacturing process, to protect, support or enhance stability, and bioavailability of the drug. Pharmaceutical excipients help in transporting the active drug to the site in the body where the drug is intended to exert its action as well as keep the drug from being released too early in the assimilation process in places where it could damage tender tissue and create gastric irritation or stomach upset. Thus, the global rise of the pharmaceutical industry propelled by the increasing demand for generic drugs is driving the global pharmaceutical excipients market.

Report Description:

The base year for the study has been considered 2017, historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The global pharmaceutical excipients market is analysed on the basis of value (USD Billion).
The study delivers a comprehensive analysis of global pharmaceutical excipients market by type, functionality, formulation and regions. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
Porter’s Five Forces model is used in order to recognize the competitive scenario in the global pharmaceutical excipients market. This report incorporates the industry analysis which is focused on providing an extensive view of the pharmaceutical excipients market.
The study also includes attractiveness analysis of type, functionality, formulation and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
The report provides company profile of the key players operating in the pharmaceutical excipients market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

Global surge in the sale of generic drugs
Rising use of biopharmaceuticals
Rising geriatric population
Increasing incidence of the chronic diseases

Restrains:

Stringent regulatory approval process

Opportunities:

Increasing demand for the pharmaceuticals from the developing economies
Development of multifunctional excipients
Growth of the biosimilars

Challenges:

Cost and time intensive drug development process
Concerns related to safety and quality

Global Pharmaceutical Excipients Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global pharmaceutical excipients market has been segmented on the basis of type, functionality, formulation and regions.

Type segment is divided into organic excipients, inorganic excipients, and others. The organic pharmaceutical excipients segment emerged as the largest type segment with a 42.89% share of market revenue in 2017. This increased market share can be attributed to the increased efficacy in oral delivery of poorly soluble molecules along with increased compressibility and flowability properties of the organic pharmaceutical excipients.
The functionality segment contains fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and others. The fillers & diluents segment led the global pharmaceutical excipients market with a 32.28% share of market revenue in 2017. The fillers & diluents materials help in improving the taste of the formulation and provide the ease of administration coupled with providing the stability, ease in preparation, packaging, shipping, and dispensing of pharmaceutical drugs.
Formulation is segmented into oral formulations, topical formulations, parenteral formulations and others. The oral formulation segment dominated the global pharmaceutical excipients market with a 39.32% share of market revenue in 2017. This increased demand can be credited to the fact that the oral route of administration is the most common and traditional route for drug delivery. However, the parenteral formulations segment is anticipated to grow the highest CAGR of 7.72% over the forecast period. Factors such as the emergence of new biologics and biosimilars delivered through the parenteral route are expected to drive this increased growth.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. The Europe region emerged as the largest market for the pharmaceutical excipients with a 41.53% share of market revenue in 2017.

Presence of major substantial elderly population, well developed pharmaceutical and healthcare industry as well as huge capacity expansion projects undertaken by the major pharmaceutical players were some of the factors that led the Europe region to lead the global pharmaceutical excipients market in 2017.
The Asia Pacific region is anticipated to grow at the fastest CAGR of 8.09% over the forecast period. This accelerated growth can be attributed to the growing demand for the generic drugs and rapid growth of the pharmaceutical manufacturing industry in the region.

Global Pharmaceutical Excipients Market Competitive Analysis:

Key players in the global pharmaceutical excipients market are Ashland, BASF SE, DowDuPont, Roquette, Evonik, Associated British Foods, Archer Daniels Midland Company, Lubrizol, Croda, Innophous Holdings, Kerry Group, Wacker Chemie, Signet, Avantor Performance Materials, Inc., FMC Corporation, Colorcon, Inc., Eastman Chemical Corporation, P&G Chemicals, Huntsman Corporation, Merck, Valeant, JRS Pharma, Shin-Etsu Chemical Co., Ltd., DFE Pharma, Finar Limited, among others. Solubility of the active pharmaceutical ingredients with poor bioavailability has been the major problem faced by the pharmaceutical industry. Thus to overcome this problem Merck in 2016, introduced the Parteck® MXP, a polyvinyl alcohol-based excipient. The Parteck® MXP enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability with.

*All our reports are customizable as per customer requirements

This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global pharmaceutical excipients market on the basis of below mentioned segments:

Global Pharmaceutical Excipients Market by Type:

Organic Chemicals
- Oleochemicals
  - Fatty Alcohols
  - Mineral Stearates
  - Glycerin
  - Others
- Carbohydrates
  - Sugars
    - Actual Sugars
      - Lactose
      - Sucrose
      - Dextrose
    - Sugar Alcohols
      - Sorbitol
      - Mannitol
      - Others
    - Artificial Sweeteners
  - Cellulose
    - Microcrystalline Cellulose
    - Cellulose Ethers
    - CMC and Croscarmellose Sodium
    - Cellulose Esters
  - Starch
    - Modified Starch
    - Dried Starch
    - Converted Starch
- Petrochemicals
  - Glycols
    - Polyethylene Glycol
    - Prolylene Glycol
  - Povidones
  - Mineral Hydrocarbons
    - Petrolatum
    - Mineral Waxes
    - Mineral Oils
  - Acrylic Polymers
  - Others
- Protein
- Others
Inorganic Chemicals
- Calcium Phosphates
- Metal Oxides
- Halites
- Calcium Carbonates
- Calcium Sulfates
- Others
Others

Global Pharmaceutical Excipients Market by Functionality:

Fillers & Diluents
Suspending & Viscosity Agents
Coating Agents
Binders
Disintegrants
Flavoring Agents & Sweeteners
Lubricants & Glidants
Colorants
Preservatives
Emulsifying Agents
Other Functionalities

Global Pharmaceutical Excipients Market by Formulation:

Oral Formulations
- Tablets
- Liquid Formulations
- Capsules
  - Hard Gelatin Capsules
  - Soft Gelatin Capsules
Topical Formulations
Parenteral Formulations
Others

Global Pharmaceutical Excipients Market by Region:

North America

U.S.
Canada
Mexico

Europe

Germany
France
Sweden
Netherlands
U.K.
Italy
Spain
Turkey
Switzerland
Belgium
Rest of Europe

Asia-Pacific

Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Rest of Asia-Pacific

South America

Brazil
Argentina
Colombia
Rest of South America

Middle East and Africa

Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of Middle East and Africa

Request Sample Request for Customization

1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By Functionality
4.3.3. Market Attractiveness Analysis By Formulation
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends

5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Global surge in the sale of generic drugs
5.2.2. Rising use of biopharmaceuticals
5.2.3. Rising geriatric population
5.2.4. Increasing incidence of the chronic diseases
5.3. Restraints
5.3.1. Stringent regulatory approval process
5.4. Opportunities
5.4.1. Increasing demand for the pharmaceuticals from the developing economies
5.4.2. Development of multifunctional excipients
5.4.3. Growth of the biosimilars
5.5. Challenges
5.5.1. Cost and time intensive drug development process
5.5.2. Concerns related to safety and quality

6. Global Pharmaceutical Excipients Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Organic Chemicals
6.3. Inorganic Chemicals
6.4. Others

7. Global Pharmaceutical Excipients Market Analysis and Forecast, By Functionality
7.1. Segment Overview
7.2. Fillers & Diluents
7.3. Suspending & Viscosity Agents
7.4. Coating Agents
7.5. Binders
7.6. Disintegrants
7.7. Flavoring Agents & Sweeteners
7.8. Lubricants & Glidants
7.9. Colorants
7.10. Preservatives
7.11. Emulsifying Agents
7.12. Others

1. Global Pharmaceutical Excipients Market Analysis and Forecast, By Formulation
1.1. Segment Overview
1.2. Oral Formulations
1.3. Topical Formulations
1.4. Parenteral Formulations
1.5. Others

2. Global Pharmaceutical Excipients Market Analysis and Forecast, By Regional Analysis
2.1. Segment Overview
2.2. North America
2.2.1. U.S.
2.2.2. Canada
2.2.3. Mexico
2.3. Europe
2.3.1. Germany
2.3.2. France
2.3.3. Sweden
2.3.4. Netherlands
2.3.5. U.K.
2.3.6. Italy
2.3.7. Spain
2.3.8. Turkey
2.3.9. Switzerland
2.3.10. Belgium
2.3.11. Rest of Europe
2.4. Asia-Pacific
2.4.1. Japan
2.4.2. China
2.4.3. India
2.4.4. South Korea
2.4.5. Australia
2.4.6. Singapore
2.4.7. Malaysia
2.4.8. Thailand
2.4.9. Indonesia
2.4.10. Philippines
2.4.11. Rest of Asia-Pacific
2.5. South America
2.5.1. Brazil
2.5.2. Argentina
2.5.3. Colombia
2.5.4. Rest of South America
2.6. Middle East and Africa
2.6.1. Saudi Arabia
2.6.2. UAE
2.6.3. Egypt
2.6.4. Nigeria
2.6.5. South Africa
2.6.6. Rest of Middle East and Africa

3. Global Pharmaceutical Excipients Market-Competitive Landscape
3.1. Overview
3.2. Market Share of Key Players in the Pharmaceutical Excipients Market
3.2.1. Global Company Market Share
3.2.2. North America Company Market Share
3.2.3. Europe Company Market Share
3.2.4. APAC Company Market Share
3.3. Competitive Situations and Trends
3.3.1. Product Launches and Developments
3.3.2. Partnerships, Collaborations, and Agreements
3.3.3. Mergers & Acquisitions
3.3.4. Expansions

4. Company Profiles
4.1. Ashland
4.1.1. Business Overview
4.1.2. Company Snapshot
4.1.3. Company Market Share Analysis
4.1.4. Company Product Portfolio
4.1.5. Recent Developments
4.1.6. SWOT Analysis
4.2. BASF SE
4.2.1. Business Overview
4.2.2. Company Snapshot
4.2.3. Company Market Share Analysis
4.2.4. Company Product Portfolio
4.2.5. Recent Developments
4.2.6. SWOT Analysis
4.3. DowDuPont
4.3.1. Business Overview
4.3.2. Company Snapshot
4.3.3. Company Market Share Analysis
4.3.4. Company Product Portfolio
4.3.5. Recent Developments
4.3.6. SWOT Analysis
4.4. Roquette
4.4.1. Business Overview
4.4.2. Company Snapshot
4.4.3. Company Market Share Analysis
4.4.4. Company Product Portfolio
4.4.5. Recent Developments
4.4.6. SWOT Analysis
4.5. Evonik
4.5.1. Business Overview
4.5.2. Company Snapshot
4.5.3. Company Market Share Analysis
4.5.4. Company Product Portfolio
4.5.5. Recent Developments
4.5.6. SWOT Analysis
4.6. Associated British Foods
4.6.1. Business Overview
4.6.2. Company Snapshot
4.6.3. Company Market Share Analysis
4.6.4. Company Product Portfolio
4.6.5. Recent Developments
4.6.6. SWOT Analysis
4.7. Archer Daniels Midland Company
4.7.1. Business Overview
4.7.2. Company Snapshot
4.7.3. Company Market Share Analysis
4.7.4. Company Product Portfolio
4.7.5. Recent Developments
4.7.6. SWOT Analysis
4.8. Lubrizol
4.8.1. Business Overview
4.8.2. Company Snapshot
4.8.3. Company Market Share Analysis
4.8.4. Company Product Portfolio
4.8.5. Recent Developments
4.8.6. SWOT Analysis
4.9. Croda
4.9.1. Business Overview
4.9.2. Company Snapshot
4.9.3. Company Market Share Analysis
4.9.4. Company Product Portfolio
4.9.5. Recent Developments
4.9.6. SWOT Analysis
4.10. Innophous Holdings
4.10.1. Business Overview
4.10.2. Company Snapshot
4.10.3. Company Market Share Analysis
4.10.4. Company Product Portfolio
4.10.5. Recent Developments
4.10.6. SWOT Analysis
4.11. Kerry Group
4.11.1. Business Overview
4.11.2. Company Snapshot
4.11.3. Company Market Share Analysis
4.11.4. Company Product Portfolio
4.11.5. Recent Developments
4.11.6. SWOT Analysis
4.12. Wacker Chemie
4.12.1. Business Overview
4.12.2. Company Snapshot
4.12.3. Company Market Share Analysis
4.12.4. Company Product Portfolio
4.12.5. Recent Developments
4.12.6. SWOT Analysis
4.13. Signet
4.13.1. Business Overview
4.13.2. Company Snapshot
4.13.3. Company Market Share Analysis
4.13.4. Company Product Portfolio
4.13.5. Recent Developments
4.13.6. SWOT Analysis
4.14. Avantor Performance Materials, Inc
4.14.1. Business Overview
4.14.2. Company Snapshot
4.14.3. Company Market Share Analysis
4.14.4. Company Product Portfolio
4.14.5. Recent Developments
4.14.6. SWOT Analysis
4.15. FMC Corporation
4.15.1. Business Overview
4.15.2. Company Snapshot
4.15.3. Company Market Share Analysis
4.15.4. Company Product Portfolio
4.15.5. Recent Developments
4.15.6. SWOT Analysis
4.16. Colorcon
4.16.1. Business Overview
4.16.2. Company Snapshot
4.16.3. Company Market Share Analysis
4.16.4. Company Product Portfolio
4.16.5. Recent Developments
4.16.6. SWOT Analysis
4.17. Eastman Chemical Corporation
4.17.1. Business Overview
4.17.2. Company Snapshot
4.17.3. Company Market Share Analysis
4.17.4. Company Product Portfolio
4.17.5. Recent Developments
4.17.6. SWOT Analysis
4.18. P&G Chemicals
4.18.1. Business Overview
4.18.2. Company Snapshot
4.18.3. Company Market Share Analysis
4.18.4. Company Product Portfolio
4.18.5. Recent Developments
4.18.6. SWOT Analysis
4.19. Huntsman Corporation
4.19.1. Business Overview
4.19.2. Company Snapshot
4.19.3. Company Market Share Analysis
4.19.4. Company Product Portfolio
4.19.5. Recent Developments
4.19.6. SWOT Analysis
4.20. Merck
4.20.1. Business Overview
4.20.2. Company Snapshot
4.20.3. Company Market Share Analysis
4.20.4. Company Product Portfolio
4.20.5. Recent Developments
4.20.6. SWOT Analysis
4.21. Valeant
4.21.1. Business Overview
4.21.2. Company Snapshot
4.21.3. Company Market Share Analysis
4.21.4. Company Product Portfolio
4.21.5. Recent Developments
4.21.6. SWOT Analysis
4.22. JRS Pharma
4.22.1. Business Overview
4.22.2. Company Snapshot
4.22.3. Company Market Share Analysis
4.22.4. Company Product Portfolio
4.22.5. Recent Developments
4.22.6. SWOT Analysis
4.23. Shin-Etsu Chemical Co., Ltd.
4.23.1. Business Overview
4.23.2. Company Snapshot
4.23.3. Company Market Share Analysis
4.23.4. Company Product Portfolio
4.23.5. Recent Developments
4.23.6. SWOT Analysis
4.24. DFE Pharma
4.24.1. Business Overview
4.24.2. Company Snapshot
4.24.3. Company Market Share Analysis
4.24.4. Company Product Portfolio
4.24.5. Recent Developments
4.24.6. SWOT Analysis
4.25. Finar Limited
4.25.1. Business Overview
4.25.2. Company Snapshot
4.25.3. Company Market Share Analysis
4.25.4. Company Product Portfolio
4.25.5. Recent Developments
4.25.6. SWOT Analysis

List of Figures

1. Global Pharmaceutical Excipients Market Segmentation

2. Pharmaceutical Excipients Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis

7. Value Chain Analysis

8. Global Pharmaceutical Excipients Market Attractiveness Analysis By Type

9. Global Pharmaceutical Excipients Market Attractiveness Analysis By Functionality

10. Global Pharmaceutical Excipients Market Attractiveness Analysis By Formulation

11. Global Pharmaceutical Excipients Market Attractiveness Analysis By Region

12. Global Pharmaceutical Excipients Market: Dynamics

13. Global Pharmaceutical Excipients Market Share By Type (2017 & 2025)

14. Global Pharmaceutical Excipients Market Share By Functionality (2017 & 2025)

15. Global Pharmaceutical Excipients Market Share By Formulation (2017 & 2025)

16. Global Pharmaceutical Excipients Market Share By Regions (2017 & 2025)

17. Global Pharmaceutical Excipients Market Share By Company (2018)

List of Table

1. Global Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

2. Global Pharmaceutical Excipients Market, By Organic Chemicals, 2015–2025 (USD Billion)

3. Global Organic Chemicals Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

4. Global Pharmaceutical Excipients Market, By Inorganic Chemicals, 2015–2025 (USD Billion)

5. Global Inorganic Chemicals Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

6. Global Others Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

7. Global Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

8. Global Fillers & Diluents Pharmaceutical Excipients Market, BY Region, 2015–2025 (USD Billion)

9. Global Suspending & Viscosity Agents Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

10. Global Coating Agents Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

11. Global Binders Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

12. Global Disintegrants Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

13. Global Flavouring Agents & Sweeteners Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

14. Global Lubricants & Glidants Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

15. Global Colorants Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

16. Global Preservatives Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

17. Global Emulsifying Agents Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

18. Global Others Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

19. Global Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

20. Global Oral Formulations Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

21. Global Topical Formulations Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

22. Global Parenteral Formulations Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

23. Global Others Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

24. Global Pharmaceutical Excipients Market, By Region, 2015–2025 (USD Billion)

25. North America Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

26. North America Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

27. North America Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

28. U.S. Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

29. U.S. Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

30. U.S. Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

31. Canada Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

32. Canada Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

33. Canada Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

34. Mexico Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

35. Mexico Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

36. Mexico Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

37. Europe Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

38. Europe Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

39. Europe Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

40. Germany Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

41. Germany Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

42. Germany Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

43. France Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

44. France Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

45. France Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

46. Sweden Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

47. Sweden Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

48. Sweden Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

49. Netherlands Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

50. Netherlands Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

51. Netherlands Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

52. U.K. Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

53. U.K. Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

54. U.K. Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

55. Italy Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

56. Italy Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

57. Italy Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

58. Spain Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

59. Spain Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

60. Spain Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

61. Turkey Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

62. Turkey Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

63. Turkey Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

64. Switzerland Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

65. Switzerland Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

66. Switzerland Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

67. Belgium Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

68. Belgium Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

69. Belgium Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

70. Asia Pacific Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

71. Asia Pacific Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

72. Asia Pacific Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

73. Japan Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

74. Japan Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

75. Japan Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

76. China Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

77. China Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

78. China Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

79. India Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

80. India Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

81. India Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

82. South Korea Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

83. South Korea Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

84. South Korea Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

85. Australia Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

86. Australia Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

87. Australia Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

88. Singapore Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

89. Singapore Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

90. Singapore Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

91. Malaysia Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

92. Malaysia Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

93. Malaysia Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

94. Thailand Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

95. Thailand Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

96. Thailand Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

97. Indonesia Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

98. Indonesia Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

99. Indonesia Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

100. Philippines Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

101. Philippines Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

102. Philippines Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

103. South America Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

104. South America Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

105. South America Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

106. Brazil Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

107. Brazil Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

108. Brazil Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

109. Argentina Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

110. Argentina Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

111. Argentina Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

112. Colombia Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

113. Colombia Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

114. Colombia Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

115. Middle East and Africa Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

116. Middle East and Africa Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

117. Middle East and Africa Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

118. Saudi Arabia Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

119. Saudi Arabia Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

120. Saudi Arabia Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

121. UAE Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

122. UAE Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

123. UAE Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

124. Egypt Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

125. Egypt Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

126. Egypt Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

127. Nigeria Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

128. Nigeria Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

129. Nigeria Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

130. South Africa Pharmaceutical Excipients Market, By Type, 2015–2025 (USD Billion)

131. South Africa Pharmaceutical Excipients Market, By Functionality, 2015–2025 (USD Billion)

132. South Africa Pharmaceutical Excipients Market, By Formulation, 2015–2025 (USD Billion)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!